Recommendations for Coping with Leishmaniasis: A Review of Control Strategies. Centro de Convenções de Reboças Red Room 17: 00h

Similar documents
CONTROLE DAS LEISHMANIOSES O QUE FALTA FAZER? Centro de Convenções de Reboças Red Room 17: 00h

Neglected Diseases (NDs) Landscape in Brazil and South America

Cutaneous Leishmaniasis : Global overview

Control of leishmaniasis

Control of leishmaniasis

Leishmaniasis, Kala Azar(The Black Fever)

Series Editors Samuel J. Black, University of Massachusetts, Amherst, MA, US.A. J. Richard Seed, University of North Carolina, Chapel Hill, NC, US.A.

Elimination of VL in the Indian subcontinent is it achievable?

World Health Organization Department of Communicable Disease Surveillance and Response

SUMMARY. Cutaneous leishmaniasis with only skin involvement: single to multiple skin ulcers, satellite lesions and nodular lymphangitis.

Frequently Asked Questions on Visceral Leishmaniasis (Kala-azar)

Authors Chappuis, François; Alirol, Emilie; Worku, Dagemlidet T; Mueller, Yolanda; Ritmeijer, Koert

Leishmaniasis. CDR R.L. Gutierrez Oct 2014

Visceral Leishmaniasis treatment access: The reality on the ground

Epidemiological Study of Cutaneous Leishmaniasis in Tuz

Policy and technical topics: Selected neglected tropical diseases targeted for elimination: kala-azar, leprosy, yaws, filariasis and schistosomiasis

Studying the Dynamics of Visceral Leishmaniasis Epidemic in India - A System Dynamic Approach for Policy Development

Proceedings of the World Small Animal Veterinary Association Sydney, Australia 2007

World Survey of Rabies No 34

Summary of Cases & Epidemiology Aspects of Leishmaniasis in Thailand

CUTANEOUS LEISHMANIASIS

LEISHMANIASIS EAST AFRICA PLATFORM: FACILITATING INNOVATION AND ACCESS TO NEW TOOLS

by author Drug Therapy in African Visceral Leishmaniasis 28th ECCMID Conference, Madrid, Spain 21 April 2018

Prevalence of Cutaneous Leishmaniasis among HIV and Non-HIV Patients attending some Selected Hospitals in Jos Plateau State

Leishmaniasis in the WhO european region

Yellow fever. Key facts

HAEMOFLAGELLATES. Dr. Anuluck Junkum Department of Parasitology Faculty of Medicine

Fact sheet. Yellow fever

Leishmaniasis: A forgotten disease among neglected people

Therapeutic Options for Visceral Leishmaniasis

Visceral leishmaniasis: an endemic disease with global impact

Downloaded from:

Drivers of Infectious Disease: Connections Matter

Lyme disease in Canada: modelling,, GIS and public health action

Application for Inclusion of MILTEFOSINE on WHO Model List of Essential Medicines:

Canine leishmaniosis new concepts and insights on an expanding zoonosis: part two

Southeast European Center for Surveillance and Control of Infectious Diseases (SECID)

Joseph Njau (K) RN, RM, RPHN, BSc N Cert Applied Epidemiology

Suggested Exercises and Projects 395

Iranian J Parasitol: Vol. 8, No.3, July -Sep 2013, pp Iranian J Parasitol. Open access Journal at ijpa.tums.ac.ir

The Most Common Parasitic Infections In Yemen. Medical Parasitology

DTA3/COFUND Programme Research Project Proforma

Malaria DR. AFNAN YOUNIS

NTDs: update on the progress. Department of Control of Neglected Tropical Diseases

Leishmaniasis. MAJ Kris Paolino September 2014

PDF of Trial CTRI Website URL -

Antimonial Resistance & Combination therapy in Indian Visceral Leishmaniasis. Shyam Sundar Banaras Hindu University Varanasi, India

Leishmaniasis: Challenges for Vaccine Development

THE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026

Welcome to the Jungle! Dr Aileen Oon, 2017 Microbiology Registrar

Surveillance for Visceral Leishmaniasis in Iraq

EC research and innovation strategy and actions

Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial

WHEN FMD GOES WILD LINKING ECOLOGY, EPIDEMIOLOGY AND SURVEILLANCE. Sergei Khomenko, Tsviatko Alexandrov, Naci Bulut, Sinan Aktas, Keith Sumption

WHO Malaria Surveillance Reference Manual. Dr Abdisalan M Noor, Team Leader, Surveillance, Monitoring and Evaluation Webinar, 29 May 2018

Vector Hazard Report: Malaria, Leishmaniasis and Dengue Risk in Honduras

New insights on leishmaniasis in immunosuppressive conditions

Committee to Advise on Tropical Medicine and Travel - CATMAT. Yellow Fever Update 2018 Manitoba Travel Health Conference Yen-Giang Bui, MD, DTMH

RAM U S. D E P A R T M E N T O F H E A L T H. E D U C A T IO N. AND W E LF A R E. J u l y 1970

Copenhagen, Denmark, September August Malaria

Capacity Strengthening to Deliver a New FirstlineTreatment for Kala Azar in Eastern Africa: The Leading Role of the LEAP Platform

SUDAN BASIC COUNTRY DATA

EFSA report on scientific assistance on control and surveillance activities

HIBA ABDALRAHIM Capsca Focal Point Public Health Authority

Blood Smears Only 07 February Sample Preparation and Quality Control 12B A

Visceral Leishmaniasis in the Indian Subcontinent: Modelling Epidemiology and Control

Risk Assessment Centre on Food Chain Project link to the Delphi priorities / EFSA Strategy topics

Leishmaniasis impact and treatment access

WORLD HEALTH ORGANIZATION. Control of neurocysticercosis

SITUATION REPORT YELLOW FEVER 16 JUNE 2016 SUMMARY

BIO Parasitology Spring 2009

Duane J. Gubler, ScD Professor and Founding Director, Signature Research Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore

United States House of Representatives. I am the Executive Director of the North America office

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director

Rabies Experts Highlight Barriers to Innovation in Rabies Education and Treatment. The Wistar Institute, Philadelphia, PA

Blood Smears Only 6 October Sample Preparation and Quality Control 15B-K

Regional Initiative on Environment and Health. Work Plan Thematic Working Group (TWG) on Climate Change, Ozone Depletion and Ecosystem Changes

VISERAL LEISHMANIASI S (KALA-AZAR)

Science and Technology Research Partnership for Sustainable Development (SATREPS)

Better Training for Safer Food BTSF

Sanofi updates information on dengue vaccine. 29 November 2017 (Sanofi Press Release)


GLOBAL HIV STATISTICS

Global Climate Change and Mosquito-Borne Diseases

MESA research grants 2014

Ethiopia Malaria Financial Landscape

Safety and immunogenicity of a new Leishmania vaccine candidate ChAd63-KH

European Centre for Disease Prevention and Control. Zika virus disease

Current therapeutics for visceral leischmaniasis. F.Amri

Thank you for the opportunity to submit testimony on the Fiscal Year (FY) 2014 State

FACTS FIGURES A FUTURE

Downloaded from:

Chagas Disease in the Americas: Impacts and Opportunities for Control

Rift Valley Fever RVF. Enhancing Safe Inter-Regional Livestock Trade Dubai, United Arab Emirates June 13-16, 2011

Below you will find information about diseases, the risk of contagion, and preventive vaccinations.

in control group 7, , , ,

Epidemiological Situation of Cholera and its Response in Nepal

WMLN Case Study. Necrotizing Palate Biopsy Specimen. Youngmi Kim Sr. Microbiologist TB Lab & Parasitology Lab MS, M(ASCP)

Assessing economic vulnerability to emerging infectious disease outbreaks: Ebola versus Zika

Transcription:

Recommendations for Coping with Leishmaniasis: A Review of Control Strategies Centro de Convenções de Reboças 08.04.2014 Red Room 17: 00h

Leishmaniasis - a Global Problem Visceral 2012 300 000 cases 20,000 deaths (6.7%) 310 million at risk Southern Ethiopia Cutaneous in last 5 years 1 million cases Syria/Turkey Source:http://www.who.int/leishmaniasis/en/

A Neglected Tropical Disease Is it? Neglected Yes but not only Tropical Tropic of Cancer Tropic of Capricorn

Leishmaniasis - a serious health problem in the Americas and control strategies are precarious Estimates* of CL cases per year: 187,200 to 307,800 Estimates* of VL cases per year: 3,668 to 4,500 + Alvar J, Vélez ID, Bern C, Herrero M, et al. (2012) Leishmaniasis Worldwide and Global Estimates of Its Incidence. PLoS ONE 7(5): e35671. doi:10.1371/journal.pone.0035671 http://www.plosone.org/article/info:doi/10.1371/journal.pone.0035671

VL in Brazil From 1995 to 2011-53,633 ( 3,352) In São Paulo State from 1999 to 2012 2,146 cases with 169 deaths (7.9%) 1992 India 77,102 cases 1,049 deaths (1.4%)

Brazil - Addressing the challenge In February 2014 a 3 day forum was convened by the Brazilian Ministry of Health to discuss 3 questions on the strategies of the surveillance and control of visceral leishmaniasis. The result was a 7 page document with specific recommendations as well as suggestions for support of 12 research areas.

So why is the control of the leishmaniases so difficult?

John Snow The Principal is Simple Cholera in Soho London 1854 Find and treat the source Can this be done for American Visceral and Cutaneous leishmaniasis?

The American Leishmaniases are Zoonoses Man - tip of the iceberg Not a reservoir host 15 Leishmania species recorded in man Jeffrey Shaw ICB, USP There are 20 named neotropical Leishmania species

The 3 Control Frontiers Reservoirs Vectors (Leishmania's Achilles heel) Man

Reservoirs Cutaneous leishmaniasis Principally small sylvatic mammals but in some foci dogs are considered as sources. Feasible Control actions Habitat management Visceral Leishmaniasis principal reservoir is the dog but cats, as well as other small mammals may increase the basic reproductive rate (Ro) Control of canine infection is feasible But what method??

after Dye 1996 The impact of different control methods on canine visceral leishmaniasis

Should we treat dogs? Meglumine antimoniate Miltefosine Allopurinol Danger - Resistance In Europe this is not considered important as patients are treated with Liposomal amphotericin B (Ambisome )

Available Vaccines for canine visceral leishmaniasis LEISHMUNE (FML) LEISH-TEC CANILEISH (LiESP/QA-21 ) The levels of protection in the field are presently controversial

CANILEISH (LiESP/QA-21 ) Experimental results in Beagles Reduction but not elimination of infectiousness to sand flies A significant reduction in the number of animals that developed acute infections

A major problem with laboratory vaccination experiments Concussively shown that needle challenge is immunologically different from sand fly challenge Conclusion: The level of protection can only be assessed using infected sand flies as the source of infection

Vectors Many different species Strategies will depend on knowing the habits of the different species

Sand fly biology

Based on a vector s biology Avoid contact Rarely used It can be very efficient

Control of leisure habits Construction Company - Amapá State, Brazil High incidence of cutaneous leishmaniasis in work force resulting in loss of production Common factor the majority were hunting at night Solution prohibit hunting and entering forest at night Result number of infections fell dramatically to nearly zero Jeffrey Shaw ICB, USP Limitations only possible in controlled communities but local communities can be notified of the danger via educational programs and a advised to avoid forest as much as is possible

Time of year Serra dos Carajás, Pará State Endemic for L.(V.) braziliensis The vector Psychodopygus wellcomei hibernates in the dry season Seasonal transmission - No cases in dry season Jeffrey Shaw ICB, USP

Environmental management Potentially one of the most important control methods Why? Community based - long term sustainability. Less dependant on the availability of governmental funds (NGOs) Requirements: knowledge of vector ecology and education of population in endemic area Effectiveness: Shown to reduce the density of visceral and cutaneous leishmansis vectors

Danger of inadequate sustainability of vector control Vector population reduced Transmission rate lowered Host population s acquired immune status altered Control interrupted or stopped Return of increased transmission levels that lead to an epidemic

El Niño & La Nina 3-7 years Lasts for 6-18 months VL infections falls due to fewer vectors El Niño 1991-93 Cases/10,000 El Niño 1997-98 Fitted regression model Lu. longipalpis fluctuations linked to El Niño Source Franke et al 2002

Prop. An Ethical consideration If you reduce the sand fly population could you be reducing protection against clinical disease? 1.0 0.9 0.8 0.7 0.6 Clinical Disease rare Observed fitted 0.5 0.4 0.3 0.2 0.1 0.0 Salvaterra, Marajó - Endemic VL area where human cases are rare but Lu.longipalpis populations is high and as incidence of VL in dogs 0 10 20 30 40 50 60 70 80 Age / yrs +ve skin tests are evidence of recovery from infection 1 and are associated with sand fly saliva antibodies 2 1 Skin test +ve/age Courtenay et al unpublished observations; 2 Barral et al 2000

Canine visceral leishmaniasis Reduce or eliminate contact with the vector L. longipalpis Inseticida impregnated collars Difficulties: Loss of collar What is the minimum coverage that will cut transmission levels efficiently to dogs and man? Deltamethrin dipping/baths Improve formulation

Application of residual insecticide in the domestic environment Models have shown that ineffective control may provoke changes in vector feeding preferences Such as Dog Man

An early warning system Predicting the distribution of vector ecological niches Lu.longipalpis * MAXENT (rcp85) * Shaw et al unpublished projections

MAXENT (rcp85) An early warning system Predicting the distribution of vector ecological niches Lu.longipalpis * Predicted but first record only in 2013 * Shaw et al unpublished projections

Visceral leishmaniasis chemotherapy

New Drugs Expensive 1. Liposomal amphotericin B (Ambisome ) VL 2. Miltefosine VL/CL? Needs further evaluation 3. Paromomycin VL oral India Only available if purchased in large quantities

Global changes in the treatment regime of human visceral leishmaniasis PIB per capita Clear relationship to the national PIB* PIB Brazil 2012 Africa e Asia Southern Europe *Gradoni et al, TM&IH 2008

Leishmaniasis Diagnosis The Corner Stone of Control The methods used for man and reservoirs, such as dogs, are basically the same Accurate diagnosis is crucial for successful control

The Molecular Gap Parasitology Smear direct Histology Culture Endemic areas An urgent need for critical evaluations Diagnostic Methods Molecular Conventional PCR Nested PCR real time PCR Immunological Tests Montenegro Test Quantitative (ELISA) Qualitative Rapid Test Species Identification

An Excellent Example of Test Evaluation Clinical infectious diseases In Brazil the sensitivity of 5 kits varied from 61,5% to 92,0% but the specificity of all was high

Education & Participation Community centers and schools Present Simple Facts The life cycle How to stop being bitten Boost individual responsibility Your house and pets

Finally how to evaluate control measures? Independent assessment Development of models related to intervention

Conclusions A control method must be based on irrefutable scientific evidence of its efficacy. A control method must be tested independently and planned in collaboration with experts in statistical and epidemiological modeling and analysis. Prior to any trial or campaign the method of execution must be explained in detail to the local population to guarantee its acceptability, taking into account different fractions of that population. The viability of long term financial support must be guaranteed. If this is not available it is questionable if the campaign should be installed..